Koyfin Home > Directory > Health Care > Kindred Biosciences > Return on Equity %

Kindred Biosciences Return on Equity % Chart (KIN)

Kindred Biosciences annual/quarterly Return on Equity % from 2013 to 2020.
  • Kindred Biosciences Return on Equity % for the quarter ending June 06, 2020 was 130.43 a 146.05% increase of 190.50 year over year
  • Kindred Biosciences Return on Equity % for the last 12 months ending June 06, 2020 was -30.46 a -100.90% increase of 30.74 year over year
  • Kindred Biosciences Annual Return on Equity % for 2019 was -70.92 a 20.33% decrease of -14.42 from 2018
  • Kindred Biosciences Annual Return on Equity % for 2018 was -56.50 a 23.22% decrease of -13.12 from 2017
  • Kindred Biosciences Annual Return on Equity % for 2017 was -43.38 a 22.62% decrease of -9.81 from 2016
Other Margins & Efficiency Metrics:
  • Kindred Biosciences Return on Capital % for the quarter ending September 09, 2018 was -30.78 a 8.89% decrease of -2.73 year over year
View Chart On Koyfin

Quarterly KIN Return on Equity % Data

06/2020130.43
03/2020-127.70
12/2019-71.05
09/2019-60.07
06/2019-50.04
03/2019-60.73
12/2018-63.14
09/2018-47.37
06/2018-46.86
03/2018-49.60

Annual KIN Return on Equity % Data

2019-70.92
2018-56.50
2017-43.38
2016-33.57
2015-30.94
2014-33.44
2013-13.14